Literature DB >> 15576338

A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers.

Germán Rosas-Acosta1, William K Russell, Adeline Deyrieux, David H Russell, Van G Wilson.   

Abstract

Post-translational modification by the conjugation of small ubiquitin-like modifiers is an essential mechanism to affect protein function. Currently, only a limited number of substrates are known for most of these modifiers, thus limiting our knowledge of their role and relevance for cellular physiology. Here, we report the development of a universal strategy for proteomic studies of ubiquitin-like modifiers. This strategy involves the development of stable transfected cell lines expressing a double-tagged modifier under the control of a tightly negatively regulated promoter, the induction of the expression and conjugation of the tagged modifier to cellular proteins, the tandem affinity purification of the pool of proteins covalently modified by the tagged modifier, and the identification of the modified proteins by LC and MS. By applying this methodology to the proteomic analysis of SUMO-1 and SUMO-3, we determined that SUMO-1 and SUMO-3 are stable proteins exhibiting half-lives of over 20 h, demonstrated that sumoylation with both SUMO-1 and SUMO-3 is greatly stimulated by MG-132 and heat shock treatment, demonstrated the preferential usage of either SUMO-1 or SUMO-3 for some known SUMO substrates, and identified 122 putative SUMO substrates of which only 27 appeared to be modified by both SUMO-1 and SUMO-3. This limited overlapping in the subset of proteins modified by SUMO-1 and SUMO-3 supports that the SUMO paralogues are likely to be functionally distinct. Three of the novel putative SUMO substrates identified, namely the polypyrimidine tract-binding protein-associated splicing factor PSF, the structural microtubular component alpha-tubulin, and the GTP-binding nuclear protein Ran, were confirmed as authentic SUMO substrates. The application of this universal strategy to the identification of the pool of cellular substrates modified by other ubiquitin-like modifiers will dramatically increase our knowledge of the biological role of the different ubiquitin-like conjugations systems in the cell.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576338      PMCID: PMC3477800          DOI: 10.1074/mcp.M400149-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  60 in total

1.  In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.

Authors:  Tung-Liang Chung; He-Hsuan Hsiao; Yuh-Ying Yeh; Hui-Ling Shia; Yi-Ling Chen; Po-Huang Liang; Andrew H-J Wang; Kay-Hooi Khoo; Steven Shoei-Lung Li
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

2.  A proteome-wide approach identifies sumoylated substrate proteins in yeast.

Authors:  Vikram Govind Panse; Ulrike Hardeland; Thilo Werner; Bernhard Kuster; Ed Hurt
Journal:  J Biol Chem       Date:  2004-07-30       Impact factor: 5.157

3.  Functional transplantation of the sumoylation machinery into Escherichia coli.

Authors:  Mario Mencía; Víctor de Lorenzo
Journal:  Protein Expr Purif       Date:  2004-10       Impact factor: 1.650

4.  Global analysis of protein sumoylation in Saccharomyces cerevisiae.

Authors:  James A Wohlschlegel; Erica S Johnson; Steven I Reed; John R Yates
Journal:  J Biol Chem       Date:  2004-08-23       Impact factor: 5.157

5.  Formation and properties of S-protein complex with S-peptide-containing fusion protein.

Authors:  V N Senchenko; M V Dianova
Journal:  FEBS Lett       Date:  1994-02-21       Impact factor: 4.124

6.  PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.

Authors:  M N Boddy; K Howe; L D Etkin; E Solomon; P S Freemont
Journal:  Oncogene       Date:  1996-09-05       Impact factor: 9.867

Review 7.  ISG15: the immunological kin of ubiquitin.

Authors:  Kenneth J Ritchie; Dong-Er Zhang
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

8.  Ribonuclease S-peptide as a carrier in fusion proteins.

Authors:  J S Kim; R T Raines
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

9.  Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C.

Authors:  P B Meluh; D Koshland
Journal:  Mol Biol Cell       Date:  1995-07       Impact factor: 4.138

10.  A proteomic study of SUMO-2 target proteins.

Authors:  Alfred C O Vertegaal; Stephen C Ogg; Ellis Jaffray; Manuel S Rodriguez; Ronald T Hay; Jens S Andersen; Matthias Mann; Angus I Lamond
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

View more
  97 in total

1.  Combining isoelectric point-based fractionation, liquid chromatography and mass spectrometry to improve peptide detection and protein identification.

Authors:  Stephanie M Cologna; William K Russell; Peniel J Lim; Gyula Vigh; David H Russell
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-24       Impact factor: 3.109

2.  HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

Authors:  Phillip R Heaton; Adeline F Deyrieux; Xue-Lin Bian; Van G Wilson
Journal:  Virus Res       Date:  2011-04-12       Impact factor: 3.303

3.  High-stringency tandem affinity purification of proteins conjugated to ubiquitin-like moieties.

Authors:  Filip Golebiowski; Michael H Tatham; Akihiro Nakamura; Ronald T Hay
Journal:  Nat Protoc       Date:  2010-04-15       Impact factor: 13.491

4.  SUMO functions in constitutive transcription and during activation of inducible genes in yeast.

Authors:  Emanuel Rosonina; Sarah M Duncan; James L Manley
Journal:  Genes Dev       Date:  2010-05-26       Impact factor: 11.361

Review 5.  Post-translational modifications of microtubules.

Authors:  Dorota Wloga; Jacek Gaertig
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

6.  Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.

Authors:  Josephine A Tidwell; Christian Schmidt; Phillip Heaton; Van Wilson; Philip W Tucker
Journal:  Mol Immunol       Date:  2011-09-28       Impact factor: 4.407

7.  SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.

Authors:  Julio C Bayona; Ernesto S Nakayasu; Marc Laverrière; Clemente Aguilar; Tiago J P Sobreira; Hyungwon Choi; Alexey I Nesvizhskii; Igor C Almeida; Juan J Cazzulo; Vanina E Alvarez
Journal:  Mol Cell Proteomics       Date:  2011-08-10       Impact factor: 5.911

8.  Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma.

Authors:  Wu-Hua Guo; Li-Hua Yuan; Zhi-Hua Xiao; Dan Liu; Ji-Xiang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-26       Impact factor: 4.553

9.  Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.

Authors:  Volkan Sakin; Sebastian M Richter; He-Hsuan Hsiao; Henning Urlaub; Frauke Melchior
Journal:  J Biol Chem       Date:  2015-08-06       Impact factor: 5.157

10.  Ubiquitin-family modifications of topoisomerase I in camptothecin-treated human breast cancer cells.

Authors:  Ragu Kanagasabai; Shujun Liu; Samir Salama; Edith F Yamasaki; Liwen Zhang; Kari B Greenchurch; Robert M Snapka
Journal:  Biochemistry       Date:  2009-04-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.